CDC and Prevention Experts’ Meeting on Minimizing the Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) in the Community
Released: March 2006 On July 19-20, 2004, in Atlanta, Georgia, USA, the
Centers for Disease Control and Prevention convened a meeting of experts
representing academic medicine; local, state, and federal public health;
and other federal agencies, including the U.S. Food and Drug Administration,
the Federal Bureau of Prisons, and the Department of Defense. The goals
of the meeting were to (1) review current knowledge regarding transmission
of methicillin-resistant Staphylococcus aureus (MRSA) in the community, (2)
discuss strategies for management on the individual patient and community
level, and (3) identify areas where additional research is needed. A detailed
summary of strategies for the clinical management of MRSA in the community,
based on discussions held at this meeting, in conjunction with additional
data available as of January 2006, is available in pdf
format.
- Strategies for Clinical Management of MRSA in the Community March 2006 (24 pages/33KB) Summary of an Experts' Meeting Convened by the CDC
Date last modified: March 17,
2006
Content source:
Division of Healthcare
Quality Promotion (DHQP)
National Center for Preparedness, Detection, and Control of Infectious Diseases
Infection Control Topics
- Infection Control Home
- Healthcare-Associated Infections
- Protecting Patients
- Protecting Healthcare Workers
- Infection Control Guidelines
- Infection Control A-Z
- About DHQP